Status:
UNKNOWN
Stem Cells Therapy in Degenerative Diseases of the Retina
Lead Sponsor:
Pomeranian Medical University Szczecin
Conditions:
Retinal Degeneration
Retinitis Pigmentosa
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to test the safety and effectiveness of an autologous bone marrow-derived stem/progenitor cells administered intravitreously in the subjects with degenerative diseases of ...
Detailed Description
Degenerative diseases of the retina are challenging for ophthalmologists. This is a common term that covers heterogenous group of diseases, f.e. retinitis pigmentosa, Stargardt disease, Best's disease...
Eligibility Criteria
Inclusion
- diagnosed degenerative disease of the retina,
- age 18-65 years,
- best corrected visual acuity max. 0,2 (Snellen letter chart),
- good understanding of the protocol and willingness to consent,
- signed informed consent.
Exclusion
- concomitant eye disease (glaucoma, etc.)
- concomitant of other systemic disease or diseases,
- inflammation (high protein or lymphocytosis in the CSF), active infections.
- diabetes,
- cardio-vascular disorders,
- cancer,
- autoimmune diseases,
- renal failure,
- impaired hepatic function,
- subject unwilling or unable to comply with the requirements of the protocol,
- patient has been treated previously with any cellular therapy,
Key Trial Info
Start Date :
December 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03772938
Start Date
December 13 2018
End Date
March 31 2020
Last Update
December 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I Department of Ophthalmology
Szczecin, Poland, 70-111